What is the maximum recommended dose of omeprazole for adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose of Omeprazole

For adults with pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome), omeprazole can be dosed up to 120 mg three times daily (360 mg/day total), with daily doses greater than 80 mg administered in divided doses 1.

Adult Dosing

Standard Indications

For typical acid-related conditions in adults, the maximum recommended doses are:

  • Active duodenal ulcer: 20 mg once daily 1
  • Active benign gastric ulcer: 40 mg once daily 1
  • GERD/erosive esophagitis: 20-40 mg once daily 1
  • H. pylori eradication: 40 mg once daily (dual therapy) or 20 mg twice daily (triple therapy) 1

Pathological Hypersecretory Conditions

The highest FDA-approved doses are reserved for pathological hypersecretory conditions (Zollinger-Ellison syndrome):

  • Starting dose: 60 mg once daily 1
  • Maximum: Up to 120 mg three times daily (360 mg/day total) 1
  • Doses >80 mg/day should be divided 1
  • Treatment duration: As long as clinically indicated; some patients have been treated continuously for more than 5 years 1

This represents the absolute maximum dose documented in FDA labeling, with clinical studies demonstrating successful acid control at dosages of 20-360 mg daily (median 60-70 mg) in Zollinger-Ellison patients 2.

Pediatric Dosing

Weight-Based Dosing (Ages 2-16 years)

The effective pediatric dosage range is 0.7-3.3 mg/kg/day 3:

  • Children ≤20 kg: 10 mg once daily 1
  • Children >20 kg: 20 mg once daily 1

Important Pediatric Considerations

Children require higher per-kilogram doses than adults to achieve equivalent acid suppression 4. In clinical studies:

  • 44% of children healed with 0.7 mg/kg/day 3
  • 28% required 1.4 mg/kg/day 3
  • The full effective range extended from 0.7 to 3.5 mg/kg/day 4

The healing dose correlates with severity of esophagitis but not with age or underlying disease 4.

Critical Caveats

Hepatic Impairment

Dose reduction to 10 mg once daily is recommended for maintenance therapy in patients with any degree of hepatic impairment (Child-Pugh Class A, B, or C) 1. Bioavailability increases to nearly 100% in hepatic disease, with plasma half-life tripling to approximately 3 hours 1.

Asian Populations

Dose reduction to 10 mg once daily is recommended for Asian patients when used for maintenance of healing of erosive esophagitis 1.

Duration Considerations

While maximum doses are defined, prolonged high-dose therapy warrants caution:

  • Enterochromaffin cell hyperplasia has been demonstrated in up to 50% of children receiving PPIs for >2.5 years 3
  • Long-term use may increase risk of infections (pneumonia, gastroenteritis, candidemia) 3
  • However, omeprazole has been administered safely for up to 11 years in small numbers of children 3 and up to 5.5 years in adults 2

Common Pitfall

Do not confuse standard dosing with maximum dosing. The 20-40 mg daily doses used for typical GERD or ulcer disease are NOT the maximum doses—they are simply the standard therapeutic doses. The true maximum (360 mg/day) is reserved exclusively for pathological hypersecretory states where massive acid production requires aggressive suppression 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.